SURGICAL STRATEGIES IN MULTIDISCIPLINARY MANAGEMENT OF CROHN'S DISEASE
暂无分享,去创建一个
[1] R. Hurst,et al. Long-term Results of the Side-to-side Isoperistaltic Strictureplasty in Crohn Disease: 25-year Follow-up and Outcomes. , 2020, Annals of surgery.
[2] D. Magro,et al. Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients , 2019, Intestinal research.
[3] A. Damião,et al. Postoperative Approach for Crohn's Disease: The Right Therapy to the Right Patient. , 2018, Current drug targets.
[4] M. Olandoski,et al. Adalimumab and postoperative complications of elective intestinal resections in Crohn's disease: a propensity score case‐matched study , 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[5] F. Shanahan,et al. Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence , 2018, Journal of Crohn's & colitis.
[6] C. Buskens,et al. Short‐ and medium‐term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres , 2017, The British journal of surgery.
[7] C. Buskens,et al. ECCO-ESCP Consensus on Surgery for Crohn's Disease. , 2017, Journal of Crohn's & colitis.
[8] M. Olandoski,et al. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn’s Disease , 2017, Digestive Diseases and Sciences.
[9] S. Danese,et al. Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study , 2016, United European gastroenterology journal.
[10] R. Prescott,et al. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial , 2016, The lancet. Gastroenterology & hepatology.
[11] M. Regueiro,et al. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. , 2016, Gastroenterology.
[12] L. Gu,et al. Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn’s Disease , 2016, World Journal of Surgery.
[13] Minhu Chen,et al. Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence. , 2015, Journal of Crohn's & colitis.
[14] O. Faiz,et al. Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome. , 2015, Journal of Crohn's & colitis.
[15] S. Targan,et al. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. , 2015, Annals of surgery.
[16] Yifan Sun,et al. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies. , 2015, Journal of Crohn's & colitis.
[17] Naicheng Liu,et al. Exclusive Enteral Nutritional Therapy Can Relieve Inflammatory Bowel Stricture in Crohn’s Disease , 2014, Journal of clinical gastroenterology.
[18] Guanghou Wang,et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease , 2014, European Journal of Clinical Nutrition.
[19] A. Ford,et al. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. , 2013, Journal of Crohn's & colitis.
[20] Subrata Ghosh,et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. , 2013, Gastroenterology.
[21] Jeroen A. W. Tielbeek,et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. , 2013, Journal of Crohn's & colitis.
[22] Y. Panis,et al. Surgical management of IBD—from an open to a laparoscopic approach , 2013, Nature Reviews Gastroenterology &Hepatology.
[23] L. Kotze,et al. Complication Rates After Bowel Resections for Crohn's Disease: A Brazilian Single‐Center Comparison Between Laparoscopic And Conventional Surgery: P‐110 , 2012 .
[24] W. Sandborn,et al. Crohn's disease , 2012, The Lancet.
[25] Z. Cohen,et al. Strictureplasty in Selected Crohn’s Disease Patients Results in Acceptable Long-term Outcome , 2012, Diseases of the colon and rectum.
[26] S. Travis,et al. Influence of Risk Factors on the Safety of Ileocolic Anastomosis in Crohn’s Disease Surgery , 2012, Diseases of the colon and rectum.
[27] L. Peyrin-Biroulet,et al. Review article: the natural history of postoperative Crohn's disease recurrence , 2012, Alimentary pharmacology & therapeutics.
[28] F. Millham,et al. Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality Improvement Program patients. , 2012, Archives of surgery.
[29] S. Jacobson. Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition , 2012, Scandinavian journal of gastroenterology.
[30] B. Parry,et al. Stapled versus handsewn methods for ileocolic anastomoses. , 2011, The Cochrane database of systematic reviews.
[31] J. Gisbert,et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.
[32] L. Peyrin-Biroulet,et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease , 2011, Inflammatory bowel diseases.
[33] L. Bonomo,et al. CT enterography with polyethylene glycol solution vs CT enteroclysis in small bowel disease. , 2011, The British journal of radiology.
[34] L. Peyrin-Biroulet,et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease , 2011, Gut.
[35] A. Zinsmeister,et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. , 2010, Gastroenterology.
[36] F. Pruvot,et al. Pre‐operative management is associated with low rate of post‐operative morbidity in penetrating Crohn’s disease , 2010, Alimentary pharmacology & therapeutics.
[37] M. Regueiro,et al. Small bowel resection rates in Crohn's disease and the indication for surgery over time: Experience from a large tertiary care center , 2010, Inflammatory bowel diseases.
[38] O. Gilja,et al. Ultrasound and Inflammatory Bowel Disease , 2010, Ultrasound quarterly.
[39] Takayuki Yamamoto,et al. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: A prospective pilot study , 2009, Inflammatory bowel diseases.
[40] R. Beart,et al. Inflammatory Bowel Disease in the United States from 1998 to 2005: Has Infliximab Affected Surgical Rates? , 2009, The American surgeon.
[41] M. Regueiro,et al. Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.
[42] C. Girelli,et al. Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[43] K. Van Steen,et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort , 2008, Gut.
[44] V. Fazio,et al. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial. , 2008, Surgery.
[45] S. Finlayson,et al. Trends in Surgery for Crohn's Disease in the Era of Infliximab , 2008, Annals of Surgery.
[46] E. Vicaut,et al. Risk Factors for Intra-Abdominal Septic Complications After a First Ileocecal Resection for Crohn’s Disease: A Multivariate Analysis in 161 Consecutive Patients , 2007, Diseases of the colon and rectum.
[47] S. Danese,et al. Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens , 2007, The American Journal of Gastroenterology.
[48] P. Munkholm,et al. Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database , 2006, The American Journal of Gastroenterology.
[49] C. Dejong,et al. ESPEN Guidelines on Enteral Nutrition: Gastroenterology. , 2006, Clinical nutrition.
[50] A. Darzi,et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta‐analysis , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[51] C. Bernstein,et al. Hospitalization, Surgery, and Readmission Rates of IBD in Canada: A Population-Based Study , 2006, The American Journal of Gastroenterology.
[52] R. Thisted,et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. , 2004, Gastroenterology.
[53] J. Lewis,et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. , 2003, Gastroenterology.
[54] C. Bernstein,et al. The Incidence of Deep Venous Thrombosis and Pulmonary Embolism among Patients with Inflammatory Bowel Disease: A Population-based Cohort Study , 2001, Thrombosis and Haemostasis.
[55] M. Keighley,et al. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease , 2000, Diseases of the colon and rectum.
[56] P. Rutgeerts,et al. Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.
[57] K. Lindor,et al. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn's disease. , 1985, Mayo Clinic proceedings.
[58] S. Steele,et al. Guideline for the Surgical Management of Crohn ’ s Disease , 2015 .
[59] Takayuki Yamamoto. Prevention of Postoperative Recurrence in Crohn’s Disease , 2014, Drugs.
[60] W. Henderson,et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. , 1999, Archives of surgery.
[61] J. Rombeau,et al. Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. , 1982, American journal of surgery.